NCT02317042View on ClinicalTrials.gov

Juno Perth Clinical Trial

NATerminatedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 29, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 29, 2015

Conditions
Respiratory InsufficiencyObesity Hypoventilation SyndromeChronic Obstructive Pulmonary Disease (COPD)Neuromuscular DiseaseUpper Airway Obstruction
Interventions
DEVICE

Juno

Juno device set to ST mode with participant's current therapy settings.

DEVICE

Juno

Juno device set to AutoEPAP iVAPS mode.

DEVICE

Juno

Juno device set to Fixed EPAP iVAPS mode.

Trial Locations (2)

Unknown

Sir Charles Gairdner Hospital, Perth

University of Western Australia, Perth

Sponsors

Lead Sponsor

ResMed
All Listed Sponsors
collaborator

Sir Charles Gairdner Hospital

OTHER

collaborator

The University of Western Australia

OTHER

lead

ResMed

INDUSTRY